Translocations involving the short arm of chromosome 17 in chronic B-lymphoid disorders: Frequent occurrence of dicentric rearrangements and possible association with adverse outcome

Leukemia

Volumn 13, Issue 3, 1999, Pages 460-468

  Callet Bauchu, E ^b   Salles, G ^a   Gazzo, S ^c   Poncet, C ^c   Morel, D ^c   Pages J ^c   Coiffier, B ^a   Coeur, P ^c   Felman, P ^c  

^a UNIVERSITÉ LYON 1   (France)

^b CENTRE HOSPITALIER LYON SUD   (France)

^c NONE

Author keywords

Chromosome 17; Chronic B cell disorders; Dicentric translocation; FISH

Indexed keywords

ARTICLE; B CELL LEUKEMIA; CENTROMERE; CHROMOSOME 17P; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 17; CHRONIC LYMPHATIC LEUKEMIA; DICENTRIC CHROMOSOME; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0032973524     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401272     Document Type: Article

References (29)

1. Juliusson G, Gahrton G. Chromosome aberrations in B-cell chronic lymphocytic leukemia. Cancer Genet Cytogenet 1990; 45: 143-160.
2. Autio K, Elonen E, Teerenhovi L, Knuutila S. Cytogenetic and immunologic characterization of mitotic cells in chronic lymphocytic leukemia. Eur J Haematol 1986; 39: 289-298.
3. Perez Losada A, Wessman M, Tiainen M, Hopman AHN, Willard HF, Solé F, Caballin MR, Woessner S, Knuutila S. Trisomy 12 in chronic lymphocytic leukemia: an interphase cytogenetic study. Blood 1991; 78: 775-779.
4. Anastasi J, Le Beau MM, Vardiman JW, Fernald AA, Larson RA, Rowley JD. Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization to interphase cells: a simple and sensitive method. Blood 1992; 79: 1796-1801.
5. Raghoehier S, Kibbelaar RE, Kleiverda K, Kluin-Nelemans JC, Van Krieken JHJM, Kok F, Kluin PM. Mosaicism of trisomy 12 in chronic lymphocytic leukemia detected by non-radioactive in situ hybridization. Leukemia 1992; 6: 1220-1226.
6. Stilgenbauer S, Döhner H, Bulgay-Mörschel M, Weitz S, Bentz M, Lichter P. High frequency of monoallelic retinoblastoma gene deletion in B-cell chronic lymphoid leukemia shown by interphase cytogenetics. Blood 1993; 81: 2118-2124.
7. Döhner H, Stilgenbauer S, James MR, Benner A, Weilguni T, Bentz M, Fischer K, Hunstein W, Lichter P. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood 1997; 89: 2516-2522.
8. Offit K, Louie DC, Parsa NZ, Philippa D, Gangi M, Siebert R, Chaganti RSK. Clinical and morphologic features of B-cell small lymphocytic lymphoma with del(6)(q21q23). Blood 1994; 83: 2611-2618.
9. Juliusson G, Oscier D, Gahrton G. Cytogenetic findings and survival in B-cell chronic lymphocytic leukemia. Second International Working Party on Chromosomes in CLL (IWCCLL) compilation of data on 662 patients. Leuk Lymphoma 1991; 5: 21-25.
10. Döhner H, Fischer K, Bentz M, Hansen K, Benner A, Cabot G, Diehl D, Schlenk R, Coy J, Stilgenbauer S, Volkmann M, Galle PR, Poutska A, Hunstein W, Lichter P. p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood 1995; 85: 1580-1589.
11. Callet-Bauchu E, Rimokh R, Tigaud I, Pages J, Gazzo S, Bastion Y, Sebban C, Magaud JP, Coiffier B, Felman P. dic(4;17)(p11;p11): a new recurrent chromosomal abnormality in chronic B-lymphoid disorders. Genes Chromosom Cancer 1996; 17: 185-190.
12. Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S, Rai KR. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996; 87: 4990-4997.
13. ISCN. Mitelman F (ed). An International System for Human Cytogenetic Nomenclature. Karger: Basel, 1995.
14. Dierlamm J, Wlodarska I, Michaux L, La Starza R, Zeller W, Mecucci C, Van den Berghe H. Successful use of the same slide for consecutive fluorescence in situ hybridization experiments. Genes Chromosom Cancer 1996; 16: 261-264.
15. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. The French-American-British (FAB) cooperative group. Proposals for the classification of chronic (mature) B and T lymphoid leukemias. J Clin Pathol 1989; 42: 567-584.
16. Gaidano G, Ballerini P, Gong JZ, Inghirami G, Neri A, Newcomb EW, Magrath IT, Knowles DM, Dalla-Favera R. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 1991; 88: 5413-5417.
17. Fenaux P, Preudhomme C, Laï JL, Quiquandon I, Jonveaux P, Vanrumbeke M, Sartiaux C, Morel P, Loucheux-Lefebvre MHL, Bauters F, Berger R, Kerckaert JP. Mutations of the p53 gene in B-cell chronic lymphocytic leukemia: a report on 39 cases with cytogenetic analysis. Leukemia 1992; 6: 246-250.
18. Mitelman F. Catalog of Chromosome Aberrations in Cancer, 5th edn. Wiley-Liss: New York, 1995, pp 2810-2841.
19. Mitchell AR. The mammalian centromere: its molecular architecture. Mutat Res 1996; 372: 153-162.
20. Lee C, Wevrick R, Fisher RB, Ferguson-Smith MA, Lin CC. Human centromeric DNAs. Hum Genet 1997; 100: 291-304.
21. Johansson B, Arheden K, Höglund M, Othzen A, Bekassy AN, Turesson I, Heim S, Mitelman F. Fluorescence in situ hybridization analysis of whole-arm 7;12 translocations in hematologic malignancies. Genes Chromosom Cancer 1995; 14: 56-62.
22. Carroll JA, Raimondi SC, Williams DL, Behm FG, Borowite M, Castelberry RP, Harris MB, Patterson D, Pullen DJ, Crist WM. Tdic(9;12): a non random chromosome abnormality in childhood B-cell precursor acute lymphoblastic leukemia: a Pediatric Oncology Study group. Blood 1987; 6: 1962-1965.
23. Rieder H, Schnittger S, Bodenstein H, Schwonzen M, Wörmann B, Berkovic D, Wolf-Dieter L, Hoelzer D, Fonatsch C. dic(9;20): a new recurrent chromosome abnormality in adult acute lymphoblastic leukemia. Genes Chromosom Cancer 1995; 13: 54-61.
24. Soenen V, Preudhomme C, Roumier C, Daudignon A, Laï JL, Fenaux P. 17p deletion in acute myeloid leukemia and myelodysplastic syndrome. Analysis of breakpoints and deleted segments by fluorescence in situ. Blood 1998; 91: 1008-1015.
25. Jonveaux P, Fenaux P, Quiquandon I, Pignon JM, Laï JL, Loucheux-Lefebvre MHL, Goosens M, Bauters F, Berger R. Mutations in the p53 gene in myelodysplastics syndromes. Oncogene 1991; 6: 2243-2247.
26. Kelman Z, Prokocimer M, Peller S, Kahn Y, Rechavi G, Manor Y, Cohen A, Rotter V. Rearrangements of the p53 gene in Philadelphia chromosome positive chronic myelogenous leukemia. Blood 1989; 74: 2318-2324.
27. El Rouby S, Thomas A, Costin D, Rosenberg CR, Potmesil M, Silber R, Newcomb E. p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression. Blood 1993; 82: 3452-3459.
28. Matutes E, Oscier D, Garcia-Marco J, Ellis J, Copplestone A, Gillingham R, Hamblin T, Lens D, Swanwbury GJ, Catovsky D. Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients. Br J Haematol 1996; 92: 382-388.
29. Lens D, Dyer MJS, Garcia-Marco JM, De Schouwer PJJC, Hamoudi RA, Jones D, Farahat N, Matutes E, Catovsky D. p53 abnormalities in CLL are associated with excess of prolymphocytes and poor prognosis. Br J Haematol 1997; 99: 848-857.